News

Optimizing the Biodecontamination process to minimize production downtime

A multi-national vaccine manufacturer approached Bioquell in order to perform a Biodecontamination within its FDA approved facility. The facility itself, some 5,500 cubic meters, was treated as a single Biodecontamination enclosure with the entire process completed within 30 hours. After a successful deployment of the project,the customer contacted Bioquell wishing to establish an industry leading […]

Read More

Leading bioprocessing institute to use new QUBE aseptic workstation

The latest generation isolator was installed at the National Institute for Bioprocessing Research and Training (NIBRT) based in Dublin, Ireland, this February. The Bioquell QUBE, a flexible aseptic workstation, is now up and running to assist with continual professional development at this leading institute for the life sciences industry. From order to installation, it only […]

Read More

Tennessee Hospital Identifies Genetic Mutation in VRE

A team from St Jude’s Hospital in Memphis, Tennessee have identified a genetic mutation within a VRE bacteria that appears to confer wide ranging antibiotic tolerance, particularly in a biofilm presentation. Published in January’s edition of mBIO (American Society for Microbiology) the research findings came about due to an extremely difficult case of bacteraemia in a 6 […]

Read More